Ontology highlight
ABSTRACT:
SUBMITTER: Chhabra S
PROVIDER: S-EPMC6234373 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
Chhabra Saurabh S Ahn Kwang Woo KW Hu Zhen-Huan ZH Jain Sandeep S Assal Amer A Cerny Jan J Copelan Edward A EA Daly Andrew A DeFilipp Zachariah Z Gadalla Shahinaz M SM Gale Robert Peter RP Ganguly Siddhartha S Hamilton Betty K BK Hildebrandt Gerhard Carl GC Hsu Jack W JW Inamoto Yoshihiro Y Kanate Abraham S AS Khoury H Jean HJ Lazarus Hillard M HM Litzow Mark R MR Nathan Sunita S Olsson Richard F RF Pawarode Attaphol A Ringden Olle O Rowe Jacob M JM Saad Ayman A Savani Bipin N BN Schouten Harry C HC Seo Sachiko S Shah Nirav N NN Solh Melhem M Stuart Robert K RK Ustun Celalettin C Woolfrey Ann E AE Yared Jean A JA Alyea Edwin P EP Kalaycio Matt E ME Popat Uday U Sobecks Ronald M RM Saber Wael W
Blood advances 20181101 21
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment of chronic myeloid leukemia (CML). Optimal conditioning intensity for allo-HCT for CML in the era of tyrosine kinase inhibitors (TKIs) is unknown. Using the Center for International Blood and Marrow Transplant Research database, we sought to determine whether reduced-intensity/nonmyeloablative conditioning (RIC) allo-HCT and myeloablative conditioning (MAC) result in similar outcomes in CML patients. We ...[more]